News | News By Subject | News by Disease News By Date | Search News

Conjunctivitis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Struggling Eleven Bio (EBIO) Forges Deal Worth $270 Million with Pharma Giant Roche (RHHBY)     6/13/2016
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
BioSante Pharmaceuticals, Inc. (BPA) Signs License Option Agreement With European Pharmaceutical Company; Deal Potentially Worth More Than $10 Million     9/14/2005
PediaMed Pharmaceuticals, Inc. Enters Into Pediatric Co-Promotion Agreement With Allergan Inc. (AGN) For ZYMAR     2/16/2005
Allergan Inc. (AGN) And Inspire Pharmaceuticals (ISPH) Enter Into Collaboration To Co-Promote Elestat In The U.S.     12/9/2003

News from Around the Web

Press Releases
Noveome Initiates Phase 2 Clinical Trial Of ST266 For The Treatment Of Allergic Conjunctivitis     12/5/2016
Ocular Therapeutix (OCUL) Begins Enrollment In Its Second Phase III Clinical Trial For DEXTENZA For The Treatment Of Allergic Conjunctivitis     11/24/2015
Ocular Therapeutix (OCUL) Expands Its Board Of Directors With The Election Of Industry Leader W. James O’Shea     11/10/2015
Eleven Biotherapeutics (EBIO) Reports Third Quarter 2015 Financial Results     11/4/2015
Starpharma Holdings Ltd's Dendrimer a Potential Viral Conjunctivitis Treatment     5/13/2013
ISTA Pharmaceuticals, Inc. (ISTA) Highlights BEPREVE(R) Clinical Data at the 2011 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting     3/23/2011
Foresight Biotherapeutics Announces Initiation of Viral Conjunctivitis Clinical Trial     7/28/2009
ISTA Pharmaceuticals, Inc. (ISTA) Submits Investigational New Drug Application For Eye Drop Formulation Of Bepotastine For The Treatment Of Allergic Conjunctivitis     12/21/2006
InSite Vision (ISV) Announces FDA Acceptance Of New Drug Application For Review     8/28/2006
InSite Vision (ISV) Meets With The FDA On Pre-NDA Discussions For AzaSite     6/22/2005
InSite Vision (ISV) Opens More Than 100 Clinical Sites For AzaSite Pivotal Phase 3 Trials     10/13/2004
Bausch & Lomb (BOL) Receives FDA Approval To Make And Sell Ciprofloxacin, Generic Anti-Infective Drug     6/9/2004
Inspire Pharmaceuticals (ISPH) Reports Fourth Quarter And 2003 Financial Results And Provides 2004 Financial Guidance     2/12/2004